We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Preventing Accumulation of Senescent Cells Reverses Adverse Signs of Aging

By LabMedica International staff writers
Posted on 15 Jan 2019
Print article
Image: Drug treatment eliminates senescent cells from tissues of old mice. The blue staining shows senescent cells in lung and liver tissue. The amount of the staining is significantly reduced following the drug treatment (Photo courtesy of The Weizmann Institute of Science).
Image: Drug treatment eliminates senescent cells from tissues of old mice. The blue staining shows senescent cells in lung and liver tissue. The amount of the staining is significantly reduced following the drug treatment (Photo courtesy of The Weizmann Institute of Science).
Researchers working with mouse models have shown that some of the less desirable signs of aging, such as chronic inflammation and reduced function of some organs, could be reversed by treatment to reduce the number of senescent cells that have accumulated in the animal.

Senescent cells are aged or damaged cells that accumulate in tissues in advanced age. They no longer are able to perform their normal roles and interfere with the functioning of the tissue in which they accumulate. Elimination of senescent cells is considered to be a promising therapeutic approach.

The extent of immune-system involvement in regulating age-related accumulation of senescent cells, and its consequences, are unknown. To evaluate the role of the immune system in the aging process, investigators at the Weizmann Institute of Science (Rehovot, Israel) worked with Prf1−/− mice with impaired cell cytotoxicity, which suffered from chronic inflammation, and with progeroid (progeroid means "resembling premature aging") mice with impaired cell cytotoxicity that promoted senescent-cell accumulation and shortened lifespan.

The investigators reported in the December 21, 2018, online edition of the journal Nature Communications that Prf1−/− mice with impaired cell cytotoxicity exhibited both higher senescent cell tissue burden and chronic inflammation. They suffered from multiple age-related disorders and lower survival. The accumulation of senescent cells in these Prf1−/− mice was accompanied by a progressive state of chronic inflammation, followed by increased tissue fibrosis and other types of tissue damage, as well as compromised organ functionality. The poor health of old Prf1−/− mice was associated with fitness reduction, weight loss, kyphosis (abnormally excessive convex curvature of the spine), older appearance, and shorter lifespan than that of wild type controls.

The investigators reported that elimination of senescent cells from old Prf1−/− mice could be achieved by pharmacological inhibitors of the BCL-2 family of proteins, such as ABT-737. First developed for potential cancer chemotherapy, ABT-737 was subsequently identified as a senolytic (a drug that selectively induces cell death in senescent cells). This pharmacological approach attenuated age-related phenotypes and gene expression profile in Prf1−/− mice. Furthermore, implementation of this approach on Prf1−/− progeroid mice increased median lifespan of these animals.

These findings shed new light on mechanisms governing senescent-cell presence in aging, and could motivate new strategies for regenerative medicine.

Related Links:
Weizmann Institute of Science

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.